Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenues	$ 303,284	$ 200,720	$ 600,784	$ 324,470
Cost of Sales	83,226	21,162	194,000	34,156
Gross Profit	220,058	179,558	406,784	290,314
Operating Expenses:
Sales and Marketing	787,262	620,307	1,408,974	1,154,720
Research and Development	261,433	465,174	601,946	852,689
General and Administrative	1,236,730	1,267,117	2,305,548	2,500,378
Total Operating Expenses	2,285,425	2,352,598	4,316,468	4,507,787
Operating Loss	(2,065,367)	(2,173,040)	(3,909,684)	(4,217,473)
Other (Expense) Income
Loss on Disposal of Assets			(149,125)
Unrealized Loss on Change in Derivative Liabilities			(320,404)
Other Income			111,518
Interest Income			13,099
Interest Expense	(942,442)	(2,453)	(1,064,250)	(5,083)
Total Other Income (Expense)	(942,442)	(2,453)	(1,409,162)	(5,083)
Loss before taxes	(3,007,809)	(2,175,493)	(5,318,846)	(4,222,556)
Income Tax Provision
Net Loss	(3,007,809)	(2,175,493)	(5,318,846)	(4,222,556)
Less: Series B Preferred Stock Dividends	(125,000)		(153,603)
Net Loss Available to Common Stockholders	$ (3,132,809)	$ (2,175,493)	$ (5,472,449)	$ (4,222,556)
Net Loss Per Share:
Basic	$ (0.11)	$ (0.11)	$ (0.21)	$ (0.22)
Diluted	$ (0.11)	$ (0.11)	$ (0.21)	$ (0.22)
Weighted Average Common Shares Outstanding:
Basic	27,579,136	20,099,095	25,949,915	19,395,401
Diluted	27,579,136	20,099,095	25,949,915	19,395,401